Literature DB >> 10392830

Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus.

L A Martin1, B E Alger.   

Abstract

Depolarization-induced suppression of inhibition is a transient decrease in GABAergic input to a hippocampal pyramidal cell following a brief depolarization of that cell. When recorded under whole-cell voltage clamp, monosynaptic, bicuculline-sensitive, GABA(A)-mediated currents are suppressed for a period lasting up to 1 min in response to a retrograde signal released by the pyramidal cell. The depolarization-induced suppression of inhibition process affects spontaneous, action-potential-dependent inhibitory postsynaptic currents, but suppression of these currents is seldom observed in the absence of carbachol, a cholinergic agonist. Because of the central roles played by cholinergic and GABAergic transmission in the regulation of hippocampal rhythmic activity, it will be important to understand the mechanism by which carbachol facilitates the appearance of depolarization-induced suppression of inhibition. As preliminary steps in the investigation of cholinergic actions on depolarization-induced suppression of inhibition, it is necessary to determine which cholinergic receptors are involved and the degree to which activation of these receptors is required for depolarization-induced suppression of inhibition. Nicotine did not mimic the effects of carbachol, and mecamylamine, a nicotinic receptor antagonist, did not block them. In contrast, the actions of carbachol were abolished by atropine and other muscarinic receptor antagonists. The actions of antagonists with relative selectivities for various subtypes of muscarinic receptors [4-diphenylacetoxy-N-methylpiperidine methiodide, pirenzepine, 11-([2-1-piperidinyl]acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzod iaz epine-6-one] suggested that cholinergic facilitation of the occurrence of depolarization-induced suppression of inhibition is likely to be mediated through muscarinic receptors of the M1 or M3 rather than M2 subtype. Despite its potent facilitation of the occurrence of depolarization-induced suppression of inhibition, muscarinic stimulation was not required for expression of depolarization-induced suppression of inhibition. Occasionally, depolarization-induced suppression of inhibition of spontaneous inhibitory postsynaptic currents occurred in the absence of carbachol and could not be blocked by atropine, and hence was not likely to be mediated by endogenous acetylcholine. Also, depolarization-induced suppression of inhibition of monosynaptically evoked inhibitory postsynaptic currents occurred without carbachol perfusion, and this was also insensitive to atropine. Therefore, the mechanism of depolarization-induced suppression of inhibition is not dependent on muscarinic receptor activation. Nevertheless, in vivo, septal cholinergic input to the hippocampus may provide the necessary activation of interneurons to allow depolarization-induced suppression of inhibition to occur.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392830     DOI: 10.1016/s0306-4522(98)00745-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell.

Authors:  Masako Isokawa; Bradley E Alger
Journal:  J Physiol       Date:  2005-07-21       Impact factor: 5.182

2.  Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation.

Authors:  Nina Wettschureck; Mario van der Stelt; Hiroshi Tsubokawa; Heinz Krestel; Alexandra Moers; Stefania Petrosino; Günther Schütz; Vincenzo Di Marzo; Stefan Offermanns
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 3.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 4.  Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Authors:  Courtney A Bouchet; Susan L Ingram
Journal:  Pharmacol Ther       Date:  2020-01-29       Impact factor: 12.310

Review 5.  Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

6.  Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus.

Authors:  L A Martin; D S Wei; B E Alger
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

7.  Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.

Authors:  Hiroki Yoshino; Takeaki Miyamae; Gwenn Hansen; Brian Zambrowicz; Michael Flynn; Donna Pedicord; Yuval Blat; Ryan S Westphal; Robert Zaczek; David A Lewis; Guillermo Gonzalez-Burgos
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

8.  Developmental alteration of endocannabinoid retrograde signaling in the hippocampus.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurophysiol       Date:  2009-12-09       Impact factor: 2.714

Review 9.  Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).

Authors:  Marco A Diana; Alain Marty
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

10.  Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1.

Authors:  Daniel A Nagode; Ai-Hui Tang; Kun Yang; Bradley E Alger
Journal:  J Physiol       Date:  2013-11-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.